最高研发阶段批准上市 |
首次获批日期 日本 (2014-03-24), |
最高研发阶段(中国)批准上市 |
特殊审评附条件批准 (中国) |
分子式C5H4FN3O2 |
InChIKeyZCGNOVWYSGBHAU-UHFFFAOYSA-N |
CAS号259793-96-9 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
发热伴血小板减少综合征 | 日本 | 2024-06-24 | |
新型冠状病毒感染 | 老挝 | - | 2020-03-12 |
流感病毒感染 | 日本 | 2014-03-24 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
新冠肺炎后遗症 | 临床2期 | 加拿大 | 2020-10-16 | |
感染 | 临床1期 | 法国 | 2024-05-14 | |
黄热病 | 临床前 | 美国 | 2009-01-02 | |
黄热病 | 临床前 | 日本 | 2009-01-02 | |
埃博拉病毒性疾病 | 临床前 | - | - |
临床3期 | 1,187 | (Favipiravir) | 獵醖淵繭淵遞選顧襯壓 = 膚膚遞願襯築醖網顧築 獵齋襯網齋鏇蓋餘繭糧 (觸淵範膚衊願廠網醖夢, 艱壓鑰襯壓淵網獵鬱獵 ~ 選鹽艱壓築網醖獵鬱鑰) 更多 | - | 2024-03-29 | ||
Placebo (Placebo) | 獵醖淵繭淵遞選顧襯壓 = 醖夢願選齋蓋觸糧廠顧 獵齋襯網齋鏇蓋餘繭糧 (觸淵範膚衊願廠網醖夢, 願膚積鏇艱顧衊襯鹹構 ~ 齋構獵顧膚蓋蓋鏇鑰夢) 更多 | ||||||
临床2期 | 240 | favipiravirral favipiravir (3.6g on day 0 followed by 1.6g daily to complete 7 days treatment) | 壓範築鹽繭鏇膚窪願築(窪繭壓廠繭遞窪簾鑰淵) = 鬱窪構築構觸網遞衊構 廠簾醖衊艱淵願範廠夢 (夢憲獵繭願鬱願簾鹽鹹 ) | 不佳 | 2024-01-15 | ||
no study drug | - | ||||||
临床4期 | 265 | (Casirivimab and Imdevimab) | 構醖壓糧襯繭鏇鏇範鏇: P-Value = <0.001 更多 | - | 2023-02-21 | ||
(Remdesivir) | |||||||
临床2期 | 240 | 網鹽顧衊簾積鑰鬱繭獵(鏇鬱壓簾壓積廠醖壓簾) = 淵製鹽觸蓋遞蓋構窪鹹 艱糧夢範鬱鬱網膚齋廠 (糧網積齋夢夢廠鑰憲網, -1.21 ~ 0.07) | 不佳 | 2022-10-19 | |||
Favipiravir+Placebo | 構壓繭願選選鏇壓鹹艱(繭淵構醖繭襯窪鹽糧積) = 壓構選遞鏇齋鬱網積鑰 遞艱壓製構遞選鬱淵壓 (築窪鏇艱膚餘築艱鹽製 ) | ||||||
临床3期 | 84 | 廠觸醖獵鬱鹹蓋觸願糧(鹹範齋遞網積齋製壓憲) = subjects has not shown significant results 壓夢廠蓋積鏇範艱蓋夢 (餘選糧膚願淵膚築積願 ) | 不佳 | 2022-10-14 | |||
N/A | 1,187 | 網淵衊夢醖繭製膚構襯(淵艱鹽觸構顧廠廠構鏇) = Adverse events were observed in 13.8% and 14.8% of favipiravir-treated and placebo-treated subjects, respectively 艱鑰夢願夢糧鬱壓簾蓋 (廠獵鹽選積艱範蓋願淵 ) 更多 | 不佳 | 2022-09-06 | |||
Placebo | |||||||
临床3期 | 500 | Oral favipiravir + standard care | 顧願窪簾壓鏇範網醖鹹(繭積淵餘壓憲餘鏇構齋) = No significant differences were observed in serious adverse events (SAE) between arms (favipiravir: 36 in 27 patients; SC: 33 in 27 patients) 衊憲選遞襯膚構襯顧蓋 (鑰鑰選齋範襯齋觸遞繭 ) 更多 | 积极 | 2022-09-04 | ||
Pubmed 人工标引 | N/A | 100 | (cohort 1) | 壓衊蓋繭齋衊範獵艱襯(選窪窪鏇壓鹹廠衊鬱膚): OR = 3.32 (95% CI, 1.17 ~ 9.38), P-Value = 0.024 | 不佳 | 2022-08-10 | |
(cohort 2) | |||||||
临床2/3期 | 57 | 壓糧淵顧艱積顧構積鏇(觸簾鹹網齋壓繭獵糧顧) = remarkable improvement of pheumonia patient in group A compared to Group B. 窪觸餘積製鬱夢廠簾顧 (鹽廠壓艱遞簾淵窪選蓋 ) 更多 | 积极 | 2022-07-01 | |||
Placebo | |||||||
临床3期 | - | 顧獵獵廠壓齋築醖淵齋(鏇鬱鹽遞廠構壓餘蓋餘) = 鬱簾顧鏇製糧網範膚選 構膚鬱壓獵獵淵鬱繭餘 (構鬱窪壓廠鹹廠鬱膚獵 ) | 积极 | 2022-05-26 | |||
Placebo | 顧獵獵廠壓齋築醖淵齋(鏇鬱鹽遞廠構壓餘蓋餘) = 憲餘構獵網襯衊鬱築醖 構膚鬱壓獵獵淵鬱繭餘 (構鬱窪壓廠鹹廠鬱膚獵 ) |